- Journal List
- Therap Adv Gastroenterol
- v.9(3); 2016 May
- PMC4830107
"We read with interest the meta-analysis [Shen et al. 2016] in Therapeutic Advances in Gastroenterology regarding the association between caffeine and non-alcoholic fatty liver disease (NAFLD). The authors analysed separately the associations of (1) caffeine from ‘regular coffee’, which has been described elsewhere as ‘filtrated coffee’ [Anty et al. 2012], and (2) ‘total caffeine’, which included all coffee types, including espresso, and non-coffee caffeine (e.g. tea and soda). The authors found that ‘regular coffee caffeine’ but not ‘total caffeine’ was inversely associated with NAFLD fibrosis severity, and that neither was associated with NAFLD prevalence."
They also report that there was some conflicting evidence.